.5/Csx and dHAND/Hand2 are conserved transcription factors that are coexpressed in the precardiac mesoderm and early heart tube and control distinct developmental events during cardiogenesis. To understand whether Nkx2.5 and dHAND may function in overlapping genetic pathways, we generated mouse embryos lacking both Nkx2.5 and dHAND. Mice heterozygous for mutant alleles of Nkx2.5 and dHAND were viable. Although single Nkx2.5 or dHAND mutants have a morphological atrial and single ventricular chamber, Nkx2.5 ؊/؊ dHAND ؊/؊ mutants had only a single cardiac chamber which was molecularly defined as the atrium. Complete ventricular dysgenesis was observed in Nkx2.5 ؊/؊ dHAND ؊/؊ mutants; however, a precursor pool of ventricular cardiomyocytes was identified on the ventral surface of the heart tube. Because Nkx2.5 mutants failed to activate eHAND expression even in the early precardiac mesoderm, the Nkx2.5 ؊/؊ dHAND ؊/؊ phenotype appears to reflect an effectively null state of dHAND and eHAND. Cell fate analysis in dHAND mutants suggests a role of HAND genes in survival and expansion of the ventricular segment, but not in specification of ventricular cardiomyocytes. Our molecular analyses also revealed the cooperative regulation of the homeodomain protein, Irx4, by Nkx2.5 and dHAND. These studies provide the first demonstration of gene mutations that result in ablation of the entire ventricular segment of the mammalian heart, and reveal essential transcriptional pathways for ventricular formation.
INTRODUCTION
Embryonic ventricular cardiomyocytes undergo rapid proliferation, but lose the ability to substantially expand in number postnatally and are thereafter unable to repopulate areas of myocardial loss or injury. Congenital heart defects involving hypoplasia of the right or left ventricle account for 25% of all mortality from congenital heart disease in children and may be the result of defects in expansion of a precursor pool of ventricular cardiomyocytes. Interestingly, the atrial chambers and remaining ventricular chamber in such conditions are relatively normal, suggesting that separable regulatory pathways may govern cardiac chamberspecific development (Srivastava, 2001) . For these reasons, there has been much interest in understanding the regulatory networks that control segmental patterning and growth of distinct cardiac chambers.
Numerous cis-regulatory elements are known to direct transcription in a chamber-specific fashion and may contribute to segmental development of the heart (Ross et al., 1996; Li et al., 1996; Kelly et al., 1995; Xavier-Neto et al., 1999; Kuo et al., 1999) . More recently, a transcriptional basis for segmental cardiac development has begun to emerge (reviewed in Srivastava and Olson, 2000; Fishman and Olson 1997; Fishman and Chien, 1997) . For example, a homeodomain protein belonging to the Iroquois family, Irx4, directs ventricular-specific gene expression (Bao et al., 1999) and the orphan nuclear receptor, COUP-TF (chicken ovalbumin upstream promoter-transcription factor) II, is required for atrial, but not ventricular development (Pereira et al., 1999) . Members of the HRT family of hairy-related basic helix-loop-helix (bHLH) proteins, also known as Hesr, Hey, CHF, or Gridlock (Nakagawa et al., 1999; Kokubo et al., 1999; Leimeister et al., 1999; Chin et al., 2000; Zhong et al., 2000) , are expressed in a complementary fashion in the embryonic heart, with HRT1 in the atria and HRT2 in the ventricles, respectively (Nakagawa et al., 1999; Leimeister et al., 1999) .
dHAND/Hand2 and eHAND/Hand1 are closely related members of another bHLH subclass of transcription factors (Srivastava, 1999) that are highly conserved across species and are required for heart development in the chick and mouse. In chick embryos, dHAND and eHAND are coexpressed throughout the heart tube before, during, and after cardiac looping and display a degree of functional redundancy (Srivastava et al., 1995) . In mice, dHAND expression becomes specifically enhanced in the right ventricle after cardiac looping (Srivastava et al., 1997; Thomas et al., 1998a) . Mouse eHAND is expressed in left ventricular precursors but, unlike chick, is completely excluded from the right ventricular segment as early as the straight heart tube stage (Srivastava et al., 1997; Biben and Harvey, 1997) . Consistent with the expression patterns of dHAND and eHAND, mouse embryos lacking dHAND display specific hypoplasia of the right ventricle soon after cardiac looping (Srivastava et al., 1997) . The less severe left ventricular phenotype may be the result of partial compensation by eHAND in the left ventricle. eHAND-null embryos die early from placental insufficiency precluding detailed cardiac analyses (Firulli et al., 1998; Riley et al., 1998) ; however, generation of eHAND-null chimeric embryos suggests a role for eHAND in left ventricular development (Riley et al., 2000) .
In addition to the left-right polarity in cardiac ventricular gene expression, a dorsal-ventral polarity exists as early as embryonic day (E) 8.0 (straight heart tube stage) in the mouse. The ventral surface of the early heart tube becomes the outer curvature of the looped heart tube and undergoes rapid proliferation and develops trabeculations. In contrast, the dorsal surface becomes the inner curvature, and myocardial cells ultimately evacuate this region allowing for the extensive remodeling of the looping heart that is necessary for proper alignment of the cardiac inflow and outflow tracts (Mjaatvedt et al., 1998) . A model has been proposed in which cardiac chambers form by virtue of rapid "ballooning" growth along the outer curvature of segments of the heart tube (de Jong et al., 1997; Christoffels et al., 2000) . Interestingly, eHAND is expressed on the ventral surface of the straight heart tube and later along the outer, but not the inner, curvature of the looped heart (Thomas et al., 1998a, Biben and Harvey, 1997) . The significance of this differential pattern of gene expression has yet to be explored.
Nkx2.5/Csx, a member of the Nk-2 family of homeodomain proteins, is another highly conserved transcription factor (Harvey, 1996; Evans, 1999) that was identified as a mammalian orthologue of Drosophila tinman (Lints et al., 1993; Komuro and Izumo, 1993; Bodmer, 1993) . Heterozygous mutations in human NKX2.5 or mouse Nkx2.5 result in a spectrum of congenital heart defects, suggesting that this transcription factor contributes to diverse cardiac developmental pathways in mammals (Schott et al., 1998; Benson et al., 1999; Biben et al., 2000) . In mice homozygous null for Nkx2.5, the heart tube forms, but a morphological defect at the looping stage occurs, and several cardiac genes, including eHAND, are downregulated in the Nkx2.5-null ventricle (Lyons et al., 1995; Tanaka et al., 1999) .
A challenge in cardiovascular biology is to develop an understanding of the hierarchical and combinatorial networks through which critical transcription factors control the form and function of the developing heart (Sucov, 1998) . Previous studies have shown that neither Nkx2.5 nor dHAND regulate one another (Srivastava et al., 1997; Biben and Harvey, 1997) . To determine whether Nkx2.5 and the HAND proteins may function in common or parallel pathways during cardiac development, we generated mouse embryos heterozygous and homozygous null for both Nkx2.5 and dHAND. Double heterozygous mice were apparently normal. In embryos homozygous null for both Nkx2.5 and dHAND, myocardial differentiation was unaffected. However, embryos lacking both Nkx2.5 and dHAND formed only a single cardiac chamber that was molecularly defined as the atrium. Complete ventricular dysgenesis occurred, although a small pool of ventricularspecific cells was detected along the ventral surface of the atrial chamber. In vivo analysis of eHAND expression revealed that Nkx2.5 mutants failed to activate eHAND expression even in the early cardiac crescent, suggesting that the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ phenotype reflected an effectively null state of dHAND and eHAND. In the absence of any HAND gene expression in the right ventricle, right ventricular cardiomyocytes were specified but failed to expand in number and underwent programmed cell death. Finally, our results reveal a cooperative effect of Nkx2.5 and dHAND on regulation of the ventricular-specific homeodomain protein, Irx4. These results suggest that Nkx2.5 and dHAND are not essential for myocardial differentiation, but together are required for expansion of a precursor population of ventricular cardiomyocytes during mouse heart development.
MATERIALS AND METHODS

Generation of Nkx2.5
؊/؊ dHAND ؊/؊ Embryos Mice heterozygous or homozygous for an Nkx2.5 mutation (Lyons et al., 1995) or dHAND mutation (Srivastava et al., 1997) were generated and genotyped as described previously on a C57L/B6 background. Double heterozygous mice (Nkx2.5 ϩ/Ϫ dHAND ϩ/Ϫ ) were intercrossed to generate mice with all possible combinations of Nkx2.5 and dHAND gene disruptions. Pregnant mothers were sacrificed and their uteri dissected to harvest E8.0 -E10.5 embryos, which were fixed in 4% paraformaldehyde.
Breeding and Genotyping of Transgenic Mice
To generate transgenic mice in a dHAND-null background, male mice heterozygous for the MLC2V-lacZ transgene (Ross et al., 1996) were mated to dHAND heterozygous females and offspring back-crossed to generate embryos with the MLC2V-lacZ transgene in the dHAND-null background. Similar crosses were performed with Nkx2.5 heterozygous mice and mice heterozygous for a lacZ insertion into the eHAND genomic locus (Firulli et al., 1998) . Mothers were sacrificed and their uteri dissected to harvest E7.5-E9.5 embryos. Genotyping was performed as described previously (Ross et al., 1996; Firulli et al., 1998) . ␤-Galactosidase staining to detect lacZ expression was performed as described previously (Yamagishi et al., 2000) .
Histology
Wild-type, Nkx2.5, and/or dHAND mutant embryos were embedded in paraffin, and serial transverse sections were obtained at 7-m intervals. Paraffin was cleared with xylene, and sections stained with hematoxylin and eosin.
Whole-Mount and Section in Situ Hybridization
Whole-mount RNA in situ hybridizations for myosin light chain (MLC)1A, MLC2A, MLC2V, and eHAND were performed by using digoxigenin-labeled antisense riboprobes as described previously (Yamagishi et al., 2000) . In situ hybridization to mouse embryo sections was performed as described previously (Lu et al., 1998) . 35 S-labeled antisense riboprobe was synthesized with T3, T7, or SP6 RNA polymerase (MAXIscript; Ambion Inc., Austin, TX) from MLC2V, COUP-TFII, Tbx5, HRT1, HRT2, or Irx4 cDNA. Hybridization was performed on paraffin-embedded sections of E8.0 -E9.25 mouse embryos. Sources of DNAs for making probes were as follows: MLC1A, MLC2A, MLC2V, eHAND (Srivastava et al., 1997; Firulli et al., 1998) , COUP-TFII (Pereira et al., 1999) , Tbx5 , HRT1 and HRT2 (Nakagawa et al., 1999) , Irx4 (Bruneau et al., 2000) .
TUNEL Assay for Apoptosis and BrdU Incorporation
To visualize apoptotic nuclei in situ, transverse sections of E8.25 wild-type, dHAND Ϫ/Ϫ , Nkx2.5 Ϫ/Ϫ , or Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ hearts were subjected to terminal transferase-mediated dUTP-biotin nickend labeling (TUNEL) assay as previously described (Thomas et al., 1998b) . Cell proliferation assays on E8.25 wild-type, dHAND Ϫ/Ϫ , Nkx2.5 Ϫ/Ϫ , or Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ embryos were performed by intraperitoneal injection of bromo-deoxyuridine (BrdU) at a concentration of 500 mg/kg. After a 2-h pulse, embryos were removed and fixed in 4% paraformaldehyde. BrdU immunofluorescence was performed on transverse sections by incubating in BrdU primary antibody (1:50) followed by incubation in a secondary antibody (goat anti-mouse IgG-Liss. Rhodamine).
RESULTS
Nkx2.5
؊/؊ dHAND ؊/؊ Embryos Die between E9.5 and 10.5
To explore possible genetic interactions between Nkx2.5 and dHAND during embryogenesis, Nkx2.5 and dHAND heterozygous mice were intercrossed to generate double heterozygotes (Nkx2.5
mice grew normally, were fertile, and had a normal life span, although subtle morphological or physiological abnormalities could not be ruled out. Double heterozygotes were intercrossed to generate embryos homozygous null for both Nkx2.5 and dHAND (Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ ). Twenty-eight litters from the heterozygote intercrosses were examined between E8.25 and E10.5 (Table 1) . At E10.5, no embryos homozygous null for both Nkx2.5 and dHAND were observed, while embryos homozygous for each individual gene were observed with marked growth retardation. At E9.5, genotypes of embryos approximated Mendelian inheritance of both Nkx2.5 and dHAND mutant alleles, suggesting that Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants die between E9.5 and 10.5, one-half to one day earlier than embryos in which each single gene was disrupted. Little variability was observed in the cardiac phenotype of double homozygous mutant embryos (described below), indicating full phenotypic penetrance.
Cardiac Defects in Nkx2.5
Precardiac mesodermal cells form a crescent shape in the anterior part of the E7.75 embryo and subsequently converge along the midline to form a beating heart tube (Yutzey and Bader, 1995). Cardiac segmentation becomes apparent at the linear heart tube stage with the primitive right and left ventricles forming most of the fused anterior heart tube and the future atrial regions lying in the more posteriorly located sinus venosae. Subsequently, by virtue of rightward looping of the heart tube, the future right and left ventricles adopt their left-right orientation and become morphologically distinct. The atrial segment initially moves dorsal to the ventricles and the atrio-ventricular junction lies on the left side of the embryo (Figs. 1A, 1E, and 1I).
Previous studies reported that the linear heart tube failed to undergo cardiac looping in Nkx2.5 Ϫ/Ϫ mutants (Lyons et al., 1995) . Our detailed analyses show that, while looping was incomplete, the outflow tract of Nkx2.5 Ϫ/Ϫ mutants was always located on the right side, and the atrial region was located dorsally and on the left side, indicating that rightward looping of the heart tube was initiated in Nkx2.5 Ϫ/Ϫ mutants (Figs. 1B, 1F, and 1J). Heart development was arrested during the process of looping, and there grossly appeared to be only a single segment of ventricle and a 
FIG. 1. Cardiac defects in
, and frontal (I-L) views. Although ventral protrusion of a ventricular segment (v) was obvious in the wild-type, Nkx2.5 Ϫ/Ϫ and dHAND Ϫ/Ϫ embryos, only a single dorsally located chamber (dc) was present in the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants. Frontal views focus on the heart. a, atria; h, head; ot, outflow tract; rv, right ventricle; lv, left ventricle; sv, sinus venosae. segment of atrium in Nkx2.5 Ϫ/Ϫ mutants. This phenotype was identical to that of complete Csx/Nkx2.5 mutants recently described (Tanaka et al., 1999) . In dHAND Ϫ/Ϫ mutants, the future right ventricular segment was hypoplastic as reported previously (Srivastava et al., 1997) , with a single left ventricle and common atrial segment remaining (Figs. 1C, 1G , and 1K). Despite each mutant having what appeared to be a single ventricle and atrial chamber, the morphology of the looped heart tube was distinct in each mutant.
Nkx2.5 Ϫ/Ϫ dHAND ϩ/Ϫ and Nkx2.5 ϩ/Ϫ dHAND Ϫ/Ϫ embryos were indistinguishable from Nkx2.5 Ϫ/Ϫ or dHAND Ϫ/Ϫ embryos, respectively. However, in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants, only one cardiac chamber was apparent at any stage studied (Figs. 1D, 1H , and 1L; Figs. 2D, 2H, and 2L). We will refer to this chamber as the "dorsal chamber" based on its position compared to wild-type atrial and ventricular chambers. The posterior portion of this chamber was connected to bilaterally dilated sinus venosae and the anterior portion was contiguous with a thin outflow tract (Figs. 1L, 2D, and 2L). There was no ventral protrusion of the heart as seen in each single mutant (Figs. 1D and 1H ). The single chamber of the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ heart was slightly oriented to the left (Fig. 1L ). Little change in cardiac morphology was noted from E8.25 to E9.25 in the double mutants. By E9.5, double mutant embryos began to develop a pericardial effusion, indicative of cardiac failure, although the heart continued to beat rhythmically. The extraembryonic and embryonic vasculature was disrupted as in each single mutant and this likely also contributed to the embryonic lethality, although the cardiac defect was evident well before the vascular defects.
Histologic analyses confirmed the dorsal and ventral positions of distinct atrial and ventricular chambers, respectively, in Nkx2.5 mutants (Figs. 2B, 2F, and 2J) and dHAND mutants (Figs. 2C, 2G , and 2K). However, in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ double mutants, only a single dorsal chamber of the heart was apparent at any level of section with no evidence of the ventral chamber observed in each single mutant (Figs. 2D, 2H , and 2L). No formation of trabeculae and little cardiac jelly was observed in the chamber of Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants. In the most posterior part of the cardiac region, dilated sinus venosae were apparent (Fig. 2L) , indicative of hemodynamic insufficiency. Interestingly, an accumulation of cells was consistently observed in a small area in the ventral part of the single chamber that is described in further detail below (Fig.  2H, bracket) .
Specification of Atrial Cardiomyocytes in
To determine whether the single cardiac chamber in Nkx2.5
mutants had differentiated and adopted a particular chamber fate, we performed a detailed molecular analysis of the double mutant hearts. MLC-1A and -2A are some of the earliest markers of cardiomyocyte differentiation and are expressed in both atrium and ventricle during early heart development (Lyons et al., 1990; Kubalak et al., 1994) . Both MLC1A (data not shown) and MLC2A (Figs. 3A-3D ) were expressed at normal levels in each single mutant and in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ hearts between E8.25 and E9.25.
In Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants, a ventral chamber was not found and the prominent chamber resembled an atrium morphologically. We therefore examined a series of markers by in situ hybridization to determine whether the dorsal chamber in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants was indeed an atrium. COUP-TFII is a member of the steroid/thyroid hormone receptor superfamily that is expressed in mesenchymal cells throughout the embryo during organogenesis, and specifically in the atria of the developing heart (Pereira et al., 1995) . COUP-TFII was expressed at normal levels in the dorsal chamber of either Nkx2.5 Ϫ/Ϫ or dHAND Ϫ/Ϫ mu- . In WT, HRT2 was expressed in the endocardium (e) and myocardium (m) of the ventricle (v) and in the endocardium of the atrium (a) (B). In the double mutant (E), HRT2 was expressed in the endocardium and in a few myocardial cells along the ventral surface (brackets) of the single dorsal chamber (dc). In contrast, Irx4 was expressed in the ventricular myocardium of wild-type embryos (C) but was undetectable in the heart of Nkx2.5
mutants, even in the MLC2V-and HRT2-expressing cells (brackets) (F).
tants (data not shown), suggesting that these chambers had atrial characteristics and that regulation of COUP-TFII was independent of both Nkx2.5 and dHAND. Similarly, in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants, COUP-TFII was expressed in the single dorsal chamber, suggesting that this chamber may be composed of cells specified to be atrial in nature (Figs. 4A and 4D ). COUP-TFII was also expressed in mesenchymal cells throughout the embryo. HRT1 is a member of a recently described subclass of bHLH transcription factors which is expressed in the atria but not ventricles during murine cardiac development (Nakagawa et al., 1999) . Similar to COUP-TFII, HRT1 was expressed in the dorsal chamber of both Nkx2.5 Ϫ/Ϫ and dHAND Ϫ/Ϫ mutants (data not shown), and in the chamber of Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants (Figs. 4B and 4E) . Finally, expression of Tbx5, a marker of atrial and left ventricular precursors Liberatore et al., 2000) , was unaffected in Nkx2.5 and dHAND single (data not shown) or double mutants (Figs. 4C and 4F ). Taken together, these data suggest that cardiomyocyte differentiation and atrial specification occurred in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants and that the single dorsal cardiac chamber of Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ embryos was molecularly specified as an atrium.
Ventricular Dysgenesis in Nkx2.5
؊/؊ dHAND ؊/؊
Hearts
To determine whether any ventricular formation or differentiation had occurred, we examined the expression of a ventricular-specific marker, MLC2V, in Nkx2.5
embryos. MLC2V is one of the earliest markers for ventricular development and is expressed exclusively in the ventricles and not in the atrium by E8.5 in wild-type embryos (O'Brien et al., 1993) . Previous reports showed that MLC2V was downregulated in Nkx2.5-null hearts and was detectable only in a small region of the heart at E8.5-E9.0 (Lyons et al., 1995) . At E9.25, we were able to detect low levels of MLC2V expression in the ventral chamber but not in the dorsal, putative atrial, chamber of Nkx2.5 Ϫ/Ϫ mutant hearts, similar to the recently described Csx/Nkx2.5 mutant (Tanaka et al., 1999) . A sharp border of expression was evident between the ventral and dorsal regions of the looped heart tube (Figs. 5B and 5F), suggesting that two distinct chambers were present in Nkx2.5 mutants. In dHAND Ϫ/Ϫ embryos, MLC2V was exclusively expressed in the ventricle at levels similar to wild-type embryos, but was not detected in the atrial chamber (Figs. 5C and 5G). In sharp contrast, MLC2V was difficult to detect in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ hearts by whole-mount in situ hybridization at any stage, suggesting severe ventricular hypoplasia (Fig. 5D) . In Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants, MLC2V transcripts were detectable by section in situ hybridization only in the ventral region of the heart tube where an accumulation of cells was observed (Fig. 5H ). This result indicated that a small number of cardiomyocytes could express ventricular-specific markers in the absence of Nkx2.5 and dHAND and that these cells had accumulated along the ventral surface of the single cardiac chamber. However, MLC2V was not detectable throughout the remainder of the double mutant heart, consistent with the absence of a ventricular chamber.
Irx4 Expression Is Abolished in Nkx2.5
Mutant Hearts
To further investigate the molecular basis for ventricular dysgenesis in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants, we used a candidate gene approach to search for ventricular-specific transcription factors that might be dysregulated in the double mutants. The bHLH protein, HRT2, is normally expressed in the myocardial layer of the ventricles and in the endocardial layers of the atria and ventricles (Nakagawa et al., 1999) . By section in situ hybridization analysis, HRT2 transcripts were detectable in the endocardium of the presumptive atrial chamber of Nkx2.5
mutants, but were not present in most of the myocardium of this chamber. Interestingly, HRT2 transcripts were present in the ventral portion of Nkx2.5
hearts where the unusual collection of MLC2V-expressing cells was observed (Figs. 6B and 6E). These observations were consistent with the notion that specification of a subset of ventricular cells had occurred in the Nkx2.5 Ϫ/Ϫ -dHAND Ϫ/Ϫ mutant, although the number of ventricular cells was far fewer than normal and ventricular morphogenesis did not occur. To search further for mediators of ventricular dysgenesis, the expression of Irx4, a ventricularspecific homeobox gene, was examined. Irx4 has been shown to be downregulated in Nkx2.5 or dHAND single mutants, although transcripts are still detectable in the single mutants (Bruneau et al., 2000) . However, in Nkx2.5 Ϫ/Ϫ -dHAND Ϫ/Ϫ mutants, Irx4 expression was completely abolished, even in the ventrally located HRT2-and MLC2V-positive cells that would have been expected to express Irx4 (Figs. 6C and 6F ).
eHAND Expression Is Absent in Nkx2.5 Mutant Precardiac Mesoderm
While eHAND is downregulated in E9.5 Nkx2.5 mutants, it has not been clear whether this is a specific effect on eHAND regulation or if the observation may reflect the absence of a left ventricle in Nkx2.5 mutants. To determine whether Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants are effectively null for both dHAND and eHAND prior to ventricular formation, we examined the expression of eHAND in Nkx2.5 mutants at E7.75, just as the precardiac mesoderm becomes arranged into the cardiac crescent. Even at this early stage, eHAND transcripts were undetectable in Nkx2.5 mutants in the precardiac mesoderm, although robust expression was maintained in the remainder of the lateral mesoderm bilaterally (Figs. 7A and 7D ). Regulation of eHAND was studied further by crossing mice harboring a lacZ marker in the eHAND locus (Firulli et al., 1998) into the Nkx2.5-null genetic background. In this manner, we were able to demonstrate the absence of lacZ expression in the left ventricular precursors of Nkx2.5 mutants at E8.0 -E8.5 (Figs. 7B FIG. 7 . eHAND downregulation in Nkx2.5 Ϫ/Ϫ precardiac mesoderm and early heart tube. Frontal view of whole-mount in situ hybridization on E7.75 wild-type (WT) and Nkx2.5 Ϫ/Ϫ embryos revealed absence of eHAND expression in the precardiac mesoderm (pm) of and 7E). It is worth noting that no asymmetry of lacZ expression was noted along the left-right axis in the sinus venosae or lateral mesoderm (Figs. 7B and 7E) . Finally, downregulation of eHAND in E9.25 Nkx2.5 mutants was confirmed by the absence of lacZ expression in the ventricle of mutants (Figs. 7C and 7F) . Thus, mice lacking Nkx2.5 and dHAND appear to be effectively null for both dHAND and eHAND prior to cardiac formation.
Ventricular Expansion and Cell Death Defects in Mutant Hearts
Conceptually, cardiac ventricular formation can be divided into two phases: (1) the initial specification of ventricular cell lineages, and (2) subsequent expansion of the ventricular segment through a combination of cell movement and proliferation at the looping stage. The accumulation of ventricular cells along the ventral surface of the atrial chamber in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants suggests that some cardiomyocytes are specified as ventricular cardiomyocytes, but those ventricular cells may fail to increase in number to form a full chamber. Because eHAND is not expressed in the right ventricle, the right ventricular precursors of dHAND-null embryos are also effectively null for both HAND proteins. We therefore used the dHANDnull model to test the hypothesis that the HAND proteins are required for ventricular expansion. To accomplish this, we traced the fate of right ventricular cells in the dHANDnull background using mice harboring lacZ under control of the right ventricular-specific promoter of MLC2V (Ross et al., 1996) . By crossing the MLC2V-lacZ transgene into the dHAND-null background, we found that right ventricular cells were indeed specified at the straight heart tube stage in the absence of dHAND (Figs. 8A and 8C ). However, during cardiac looping when the ventricular chambers are thought to expand from the ventral surface of the heart tube, the right ventricular segment, as marked by lacZ-expressing cells, failed to expand (Figs. 8B and 8D) .
To determine whether the mechanism of ventricular hypoplasia was associated with impairments of cell proliferation or survival, transverse sections of E8.25 and E8.5 hearts were concurrently examined for alterations in levels of apoptosis and cell proliferation. The right ventricular precursors in the bulbus cordis of mice homozygous null for dHAND displayed a tremendous amount of apoptosis as determined by TUNEL assay (Fig. 9D) . Consistent with previous observations (Tanaka et al., 1999) , no changes in programmed cell death or cell proliferation were observed in wild-type or Nkx2.5 Ϫ/Ϫ mutants (Figs. 9B and 9F) . Interestingly, Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ E8.25 hearts showed minimal evidence of apoptosis on the ventral surface (Fig. 9H) , suggesting the early absence of ventricular cells or early loss of ventricular cells in the absence of both genes. Electron microscopy of tissue sections confirmed evidence of apoptosis in dHAND mutant embryos. Cell proliferation was observed at near normal levels in all mutants as determined by BrdU incorporation (data not shown). These results indicate that inappropriate apoptosis of specified ventricular cells results in failure of ventricular expansion in dHAND, but not Nkx2.5, single mutants.
DISCUSSION
Unlike in skeletal muscle, neuronal, or hematopoietic development, identification of a single transcription factor responsible for cardiogenesis in vertebrates has been elusive. Instead, a search for the aggregate factors and molecular pathways involved in ventricular and atrial development may represent a more obtainable goal. Here, we investigated the combinatorial activities of two critical transcription factors, Nkx2.5 and dHAND, involved in cardiac development. Early cardiac markers suggest that cardiomyocyte specification and differentiation can occur even in the combined absence of Nkx2.5 and dHAND. Morphologic and molecular analyses indicated that the hearts of Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ embryos became patterned into an atrium but that morphogenesis of the right and left ventricles failed to occur and embryos died between E9.5 and 10.5. A small pool of cardiomyocytes expressing ventricular-specific markers was detectable in the ventral portion of the atrial chamber but failed to form the ventricular chambers. These results provide the first demonstration of gene mutations that result in ablation of the entire ventricular segment of the mammalian heart.
Similarity of Nkx2.5
؊/؊ dHAND ؊/؊ and hands off Mutants
The Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ phenotype is reminiscent of the zebrafish mutant, hands off, that is caused by a mutation in the zebrafish dHAND gene (Yelon et al., 2000) . Zebrafish have only a single ventricle and a single HAND gene identified to date that has closest homology to dHAND (Angelo et al., 2000) . In the hands off mutant, cardiomyocyte specification occurs, but myocytes are primarily atrial and ventricular formation does not occur. An irregular distribution of ventricular myosin heavy chain in a few myocardial cells was observed. Thus, the hands off phenotype resembled the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutant in that ventricular specification occurred in some cardiomyocytes, but these cells failed to subsequently form a ventricular chamber.
In spite of these similarities, the hands off phenotype is more severe than the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ phenotype. Morphologically, hands off mutants develop two small lateral clusters of myocardial cells that never fuse together in the midline, unlike Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants that form a midline heart tube. This discrepancy may be explained by the residual eHAND expression in the lateral plate mesoderm (lm) of Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants that might compensate for the absence of dHAND in the lm. In addition to the morphologic differences, myocardial cells in hands off mutants fail to maintain Tbx5 expression. This is in contrast to the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants that demonstrate robust Tbx5 expression in the remaining atrial chamber, suggesting differences in genetic regulation of Tbx5 in mice and zebrafish.
Potential Molecular Mechanisms for Ventricular Dysgenesis
Although the phenotype of Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ embryos is unambiguous, there are several potential mechanistic interpretations. Because our studies indicate that eHAND is downregulated in the precardiac mesoderm of Nkx2.5 mutants, it is attractive to hypothesize that the phenotype of Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ mutants reflects the loss of both dHAND and eHAND expression. Similarity of the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ phenotype in the mouse and hands off phenotype in the zebrafish described above may support this hypothesis. Since dHAND and eHAND are expessed in a somewhat complementary fashion in the right and left ventricles in mice, it is possible that dHAND and eHAND may have redundant roles and are required for expansion of the right and left ventricular segment, respectively, at the looping stage (Fig. 10, model 1) . While genetic redundancy has not been established in the mouse heart, dHAND's role in anterior-posterior patterning of the limb bud (FernandezTeran et al., 2000; Charite et al., 2000) can be functionally substituted by eHAND in the limb (D. McFadden, D.S., and E.N.O., unpublished observations). Generation of a dHAND and eHAND double-null mouse using a conditional eHAND deletion is in progress and will determine the extent to which eHAND downregulation contributes to the Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ phenotype. While a simple model as described above is attractive, it is unlikely that the role of Nkx2.5 in cardiac development is solely based on its regulation of eHAND expression. Rather, it is likely that Nkx2.5 regulates genes that are independent of pathways regulated by the HAND proteins. However, the apparent genetic interaction of Nkx2.5 and dHAND-related pathways might indicate that Nkx2.5 and dHAND also synergistically regulate a set of factors important for ventricular development. While HRT2 is not regulated by either pathway, the ventricular homeobox gene, Irx4, is an example of a gene dependent on both Nkx2.5 and dHAND (Fig. 10, model 2) . The complete lack of Irx4 expression in the ventricular-specific cells of Nkx2.5 Ϫ/Ϫ -dHAND Ϫ/Ϫ mutants is more severe than the partial downregulation observed in either single mutant. Thus, it is possible that the ventricular dysgenesis also reflects the absence of Irx4 and other, yet unknown, ventricular-specific factors, that are normally regulated by Nkx2.5 and dHAND in a cooperative fashion. Determining whether Nkx2.5 and dHAND synergistically activate Irx4 will await analysis of the Irx4 regulatory region.
Ventral Expansion of Ventricular Cardiomyocytes
Concurrent with the segmental model of cardiac development, a model has been proposed in which growth of the ventral aspect of the linear heart tube gives rise to the outer curvature of the looped heart and results in ventricular expansion (de Jong et al., 1997; Christoffels et al., 2000) . The expression patterns of dHAND and eHAND are consistent with this model, with expression of eHAND on the ventral surface of the straight heart tube but not on the dorsal side (Thomas et al., 1998a; Biben and Harvey, 1997) . The ventricular remnant cells on the ventral surface of Nkx2.5 Ϫ/Ϫ -dHAND Ϫ/Ϫ hearts are a subtle but important finding. The presence of these cells, which express ventricular markers, supports the model of ballooning growth of the ventricular chamber from the ventral surface of the heart tube. In the absence of appropriate signals from the Nkx2.5 and HANDrelated pathways, the ventrally located ventricular cells may fail to expand into a ventricular segment, remaining in a more primitive state in which they occupy only the ventral surface of the heart tube. While the "ballooning" model of cardiogenesis has been inferred by cell fate analyses and gene expression domains, this observation represents some of the more convincing functional evidence supporting this model.
There are several potential mechanistic explanations for the failure of expansion of ventrally located ventricular cells in Nkx2.5 Ϫ/Ϫ dHAND Ϫ/Ϫ embryos. While our results suggest that ventricular specification may occur in at least some cells, it is possible that other preventricular cells are respecified into other cardiac lineages in the absence of Nkx2.5 and dHAND. In addition, it is worth considering that the few cells expressing ventricular markers may be doing so aberrantly and thus may not represent ventricular cells. Alternatively, the defect may lie in regulation of the number of ventricular cells available to contribute to a ventricular chamber. Although our studies indicate that cells continue to proliferate to some degree in the absence of dHAND and Nkx2.5, a marked dysregulation of apoptosis was observed. Programmed cell death had been examined previously (Tanaka et al., 1999) and, consistent with our observations, was not found to play a major role in the cardiac defects described in Nkx2.5 mutants. In contrast, apoptosis does play a role in pharyngeal arch hypoplasia in dHAND mutants (Thomas et al., 1998b) , and here we show that a similar mechanism is involved during ventricular hypoplasia, suggesting that dHAND may function to promote survival of cells during their period of rapid growth. The absence of apoptotic cells in Nkx2.5 mutants may reflect distinct functional roles of Nkx2.5 and dHAND; alternatively, the continued expression of dHAND in the ventricles of Nkx2.5 mutants may be sufficient to overcome any survival defects that might have resulted from downregulation of eHAND. The paucity of ventricular cells and the absence of apoptotic cells at E8.25 in Nkx2.5 Ϫ/Ϫ -dHAND Ϫ/Ϫ embryos may reflect an earlier loss of ventricular cardiomyocytes, possibly at the cardiac crescent stage, or altered specification of ventricular cells.
Dissection of the complex molecular pathways involved in ventricular specification, differentiation and growth will likely provide the basis for understanding the pathogenesis of hypoplastic ventricle syndromes. In addition, deciphering the molecular code for expansion of a population of cardiomyocytes will be increasingly important as efforts to generate cardiomyocytes from endogenous cardiac or noncardiac cells progress. The pathways explored here provide evidence for a molecular network that is essential for cardiomyocyte expansion and chamber formation that may be exploited in the future.
